CereMark PharmaOrganizationGet new research by emailTrialsVisualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's DiseasePhase 3, Recruiting, 230 people, Feb 12, 2024Sources: clinicaltrials.gov